News & Insights

Celebrating Data Privacy Week 2025 An Overview of SAFEs and Convertible Notes as Investment Instruments Corporate Transparency Act – FAQs Client Alert: CTA Update – Texas Case – Appeal Filed; FinCEN Position Morse Serves as Counsel to The Bridge in Acquisition of Data Consulting Firm Attorney Taimoor Choudhry Joins Morse Section 83(b) Elections – Navigating Fertile Ground for Bad Results What’s Market: Indemnification Caps and Baskets in M&A Transactions WEBINAR: 30 Mins: Navigating the Corporate Transparency Act Morse Serves as Counsel in Myeloma Investment Fund’s Investment in Envisagenics Five Steps to Preparing for Your Venture Capital Financing Preparing for Investment – How Organized are your Corporate Documents? A Few Things to Know About Founders Preferred Stock Building Resilient Biotechnology Research in the Shadow of The Biosecure Act Three Things to Consider in a Corporate Venture Capital Investment VC Deals: Morse Ranked in 18 Categories in 2023 PitchBook League Tables 2023 VC Deals 2019-2023 M&A Deals Morse Welcomes Corporate Counsel Daniel E. Wilcox Morse Announces 2024 Attorney Elevations